NEW #1: PDS Bio unseats Novavax at the top!
An incredible unstoppable run by PDS Bio, this week with a 320% gain in overall return, puts it in the #1 spot. Novavax, with a 29% overall gain falls to second. PDS Bio has now returned 908% since the beginning of the pandemic, while Novavax has returned 823%.
For the week, the average overall return for all 27 COVID VACCINE STOCKS climbed up from 168% to 183%. Much of that gain coming from PDS.
No comments:
Post a Comment